“Acorda Drug Safety staff should have SOPs, work instructions, database access, and training sufficient to ensure adequate surveillance, receipt, evaluation, follow-up, and reporting of adverse event information for all of the firm’s products.”
View the original warning letter.
All study data are handled and controlled by your Study Coordinator, who enters the data into an electronic data base. There is no audit trail or log of data changes that are made to the information in the database. Data cannot be verified against source records, since such records are not maintained.”
View the original warning letter.
View the original warning letter.
Failure to maintain the integrity and adequacy of the laboratory’s computer systems used by the Quality Control Unit in the analysis and processing of test data. For example a) There was a lack of a secure system to prevent unauthorized entry in restricted data systems. Data edit authorization rights were available to all unauthorized user not only the system administrator.
View the original warning letter .